Debrief

In this case, convergent CBC indices, smear findings, iron status, age, and fractions support a beta-thalassemia carrier pattern. The released comment should state the supported pattern and its material method or coinheritance limits.

A fractionation pattern is not a genotype. Adult HbA2 and HbF patterns are not newborn screening patterns, transfusion can mix donor and patient fractions, and method-dependent interference can change HbA2 assignment. A normal adult separation does not exclude alpha-thalassemia trait. Local validated intervals, chromatogram rules, reflex criteria, controls, calibrators, reagent lot records, and turnaround time policy govern the reportable result.

Molecular classification requires the assay and qualified interpretation. HBB sequence analysis is first-line molecular testing for beta-thalassemia, while a negative or single-variant sequence result may need deletion or duplication analysis. Molecular laboratory coverage, consent, referral, and family-study workflow are local policy decisions. Release a bounded pattern statement, document the method limits, and route correlation under current local policy.